Search for: "Anderson v. Abbott Laboratories"
Results 1 - 15
of 15
Sorted by Relevance
|
Sort by Date
8 May 2007, 5:11 am
Abbott Labs. v. [read post]
30 Jun 2023, 1:56 pm
–Editing by Marygrace Anderson. [read post]
8 Jan 2007, 7:07 am
Abbott Laboratories (06-475), involving a dispute among lower courts on when a missing filing deadline in federal courts can be excused. ** EchoStar Communications v. [read post]
16 Apr 2013, 6:51 am
It is shamelessly plagiarized from a recent brief filed by friend-of-the-blog Jay Lefkowitz and others at Kirkland in a Fifth Circuit appeal in a case called Anderson v. [read post]
7 Nov 2014, 5:52 am
Ellis v. [read post]
22 Jan 2009, 2:06 am
Specifically as to inadequate warning claims the court in Anderson v. [read post]
3 Sep 2015, 6:36 am
Health Ctr. v. [read post]
4 Jun 2018, 3:04 pm
" Flynt v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
9 Aug 2012, 5:00 am
Sanchez & Abbott Labs. [read post]
2 Mar 2012, 6:52 am
ADAC Laboratories (?) [read post]
15 Jul 2019, 5:01 am
Nixon v. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
21 Nov 2008, 1:36 pm
(IPKat) EU favours disclosure of computer patents before standards are set (Intellectual Property Watch) Trade Marks Court of First Instance finds RAUTARUUKKI fails to satisfy acquired distinctiveness criterion: Rautaruukki Oyj v OHIM (Class 46) Court of First Instance finds original signature of famous Italian lutist Antonio Stradivari, in arte Stradivarius, of the 17th century, cannot be read by relevant consumers: T‑340/06 (Catch Us If You Can!!!) [read post]
28 Jun 2008, 11:06 pm
V. [read post]
